Angiogenesis Enhances Factor IX Delivery and Persistence from Retrievable Human Bioengineered Muscle Implants

This publication has 45 references indexed in Scilit:

• Preclinical and clinical gene therapy for haemophilia
  Haemophilia, 2004
• Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
  Blood, 2004
• LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
  Science, 2003
• Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors
  Blood, 2003
• Bone marrow stromal cells as a genetic platformfor systemic delivery of therapeutic proteins in vivo: human factor IX model
  The Journal of Gene Medicine, 2002
• Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo
  Blood, 2002
• Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: concurrent tumourigenesis
  Haemophilia, 2001
• Tissue-Engineered Human Bioartificial Muscles Expressing a Foreign Recombinant Protein for Gene Therapy
  Human Gene Therapy, 1999
• Tissue-Engineered Skeletal Muscle Organoids for Reversible Gene Therapy
  Human Gene Therapy, 1996
• Efficient selection for high-expression transfectants with a novel eukaryotic vector
  Gene, 1991